OHI

Omega Healthcare Investors Inc Real Estate Real Estate Investment Trusts Russell 3000
$46.98Close $13.9BMarket cap $37.59 – $51.0352-week range Nov 3, 2026Next report · after the close

Highlights

Strengths

  • Earnings growing EPS +155% year on year, faster than the quarter before (+125 pts)

Cautions

  • Not in an uptrend 5 of 8 trend conditions
  • Results soon Nov 3, 2026, in 2 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Jul 30, 2026
Off 12-month high 8%
1wk up 1.6% price change
1mo up 1.4% price change
12-month return up 25% market up 11% · its own up 15%
F-score — — Not assessed
Altman Z — Unknown
P/E 22781.3× price / earnings
PEG 775.67 P/E / EPS growth
P/B 2.7× price / book
Earnings yield up 4.6% EBIT / enterprise value
Cheaper than — of the market · not assessed
Revenue growth up 13% year on year
EPS growth up 155% latest quarter · +125 pts
Sales growth down 95% latest quarter · +3 pts
ROE 0% return on equity
Free cash margin up 74% $878.6M FCF
D/E 0.82 long-term debt / equity
Net debt / EBITDA 3.6×
Interest cover 3.9×EBIT / interest
Piotroski tests

Repair signals

  • Long-term debt down 12% ($4.8B → $4.3B)

Trade setup

ATR% 2.1% $1.00 a day · 2×ATR $44.98
RS 56 / 99 vs the universe
Trend 5 / 8 50-day under the 150/200-day, under 30% off the low, RS under 70
Relative volume 1.2× vs 50-day average
Up/down volume 0.90 50 sessions
Implied move — no option chain · report Nov 3, 2026
Trend template · 5 of 8
  • Price above the 150 and 200-day averages: passes
  • 150-day average above the 200-day: passes
  • 200-day average rising for a month: passes
  • 50-day average above the 150 and 200-day: fails
  • Price above the 50-day average: passes
  • At least 30% above the 52-week low: fails
  • Within 25% of the 52-week high: passes
  • RS rank 70 or higher: fails

Screen verdict

Did not qualify for any screen.

Warning signs

1 flagged
  • Shareholders diluted The share count rose 5.9% over the year, from 279m to 296m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported Jul 29, 2026

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $1.2B +13% on FY2024
$0 $2B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $892.4M FY2021 · $1.1B FY2022 · $878.2M FY2023 · $949.7M FY2024 · $1.1B FY2025 · $1.2B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $609,467 +46% on FY2024
$0 $200M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $163.5M FY2021 · $428,302 FY2022 · $438,841 FY2023 · $248,796 FY2024 · $417,804 FY2025 · $609,467
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $878.6M +17% on FY2024
$0 $1B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $708.3M FY2021 · $722.1M FY2022 · $625.7M FY2023 · $617.7M FY2024 · $749.4M FY2025 · $878.6M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Net 0%
  • Free cash 74%
0% 100% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Net 18% · Free cash 79% FY2021 · Net 0% · Free cash 68% FY2022 · Net 0% · Free cash 71% FY2023 · Net 0% · Free cash 65% FY2024 · Net 0% · Free cash 71% FY2025 · Net 0% · Free cash 74%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $4.2B net debt
  • Cash
  • Long-term debt
$0 $10B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $163.5M · Long-term debt $5.2B FY2021 · Cash $20.5M · Long-term debt $5.3B FY2022 · Cash $297.1M · Long-term debt $5.3B FY2023 · Cash $442.8M · Long-term debt $5.1B FY2024 · Cash $518.3M · Long-term debt $4.8B FY2025 · Cash $27.0M · Long-term debt $4.3B
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 295.54m +27.8% since FY2020
295.54m 231.20m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 231.20m FY2021 · 239.06m FY2022 · 234.25m FY2023 · 245.28m FY2024 · 279.13m FY2025 · 295.54m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $892.4M $1.1B $878.2M $949.7M $1.1B $1.2B
Net income $163.5M $428,302 $438,841 $248,796 $417,804 $609,467
Net margin 18% 0% 0% 0% 0% 0%
Earnings per share $0.70 $0.00 $0.00 $0.00 $0.00 $0.00
Free cash flow $708.3M $722.1M $625.7M $617.7M $749.4M $878.6M
Free cash margin 79% 68% 71% 65% 71% 74%
Cash $163.5M $20.5M $297.1M $442.8M $518.3M $27.0M
Long-term debt $5.2B $5.3B $5.3B $5.1B $4.8B $4.3B
Shareholders' equity $3.8B $3.9B $3.6B $3.6B $4.5B $5.2B
Shares outstanding 231.20m 239.06m 234.25m 245.28m 279.13m 295.54m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Jul 30, 2026 Quarterly ↗ Jun 30, 2026 30d
Apr 29, 2026 Quarterly ↗ Mar 31, 2026 29d
Feb 9, 2026 Annual ↗ Dec 31, 2025 40d
Oct 31, 2025 Quarterly ↗ Sep 30, 2025 31d
Aug 1, 2025 Quarterly ↗ Jun 30, 2025 32d
May 2, 2025 Quarterly ↗ Mar 31, 2025 32d
Feb 13, 2025 Annual ↗ Dec 31, 2024 44d
Oct 31, 2024 Quarterly ↗ Sep 30, 2024 31d
Aug 2, 2024 Quarterly ↗ Jun 30, 2024 33d
May 3, 2024 Quarterly ↗ Mar 31, 2024 33d
Feb 12, 2024 Annual ↗ Dec 31, 2023 43d
Nov 3, 2023 Quarterly ↗ Sep 30, 2023 34d

Current reports